WVE SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0002012383-26-003343
WVE filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 27, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +7.5% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Wave Life Sciences, Inc. The filing indicates a change in the holder's ownership stake.
Key details
How WVE stock reacted
Close before
$3.21
Oct 26, 2026
First close after
+7.48%
$3.45
5 trading days
+9.66%
$3.52
Since filing
+4.83%
$3.37
✦ Ask GOAX AI about this filing — what it means for WVE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for WVE?
Click hereFrequently asked questions
What did WVE file with the SEC on Oct 27, 2026?
WVE filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Wave Life Sciences, Inc. The filing indicates a change in the holder's ownership stake.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did WVE stock react to this filing?
WVE closed at $3.21 before the filing and $3.45 on Oct 27, 2026 (+7.48%). Five trading days later: $3.52 (+9.66%).
Other WVE SEC filings
- 8-K · SEC filingOct 27, 2026
- 10-Q · SEC filingOct 27, 2026
- DEF 14A · Board changeOct 14, 2026
- 10-Q · SEC filingJul 30, 2026
- 8-K · SEC filingJul 30, 2026
- 8-K · SEC filingJun 26, 2026
- 8-K · Fda approvalMay 18, 2026
- DEF 14A · Board changeMay 7, 2026
- 10-K/A · RestatementApr 30, 2026
- 10-Q · SEC filingApr 28, 2026
Get alerts when WVE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days